Biblio
“Alzheimer's and Parkinson's Diseases: Expected Economic Impact on Europe-A Call for a Uniform European Strategy.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1123-1133, 2016.
, “Alzheimer's Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-β with Regard to Potential Treatment and Prevention.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1271-6, 2016.
, “Alzheimer's Disease Risk Genes and Lipid Regulators.”, J Alzheimers Dis, vol. 53, no. 1, pp. 15-29, 2016.
, “Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?”, J Alzheimers Dis, vol. 52, no. 2, pp. 417-20, 2016.
, “Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators.”, J Alzheimers Dis, vol. 54, no. 2, pp. 763-76, 2016.
, “Amyloid-β Reduces Exosome Release from Astrocytes by Enhancing JNK Phosphorylation.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1433-41, 2016.
, “Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1403-13, 2016.
, “Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression.”, J Alzheimers Dis, vol. 50, no. 3, pp. 847-57, 2016.
, “Anemia and Mild Cognitive Impairment in the German General Population.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
, “Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State.”, J Alzheimers Dis, vol. 50, no. 4, pp. 981-98, 2016.
, “The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils.”, J Alzheimers Dis, vol. 50, no. 2, pp. 517-25, 2016.
, “Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1085-97, 2016.
, “Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.”, J Alzheimers Dis, vol. 54, no. 2, pp. 679-90, 2016.
, “Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.”, J Alzheimers Dis, vol. 52, no. 3, pp. 899-911, 2016.
, “The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1485-97, 2016.
, “Anti-Viral Properties of Amyloid-β Peptides.”, J Alzheimers Dis, vol. 54, no. 3, pp. 859-878, 2016.
, “Apathy and Attentional Biases in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 3, pp. 837-46, 2016.
, “Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?”, J Alzheimers Dis, vol. 53, no. 2, pp. 639-50, 2016.
, “Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 935-48, 2016.
, “Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
, “Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.”, J Alzheimers Dis, vol. 51, no. 1, pp. 227-36, 2016.
, “Approaches to Increasing Ethical Compliance in China with Drug Trial Standards of Practice.”, J Alzheimers Dis, vol. 52, no. 3, pp. 825-7, 2016.
, “Aquaporin-4 and Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 2, pp. 391-402, 2016.
, “Artificial Neural Networks Link One-Carbon Metabolism to Gene-Promoter Methylation in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1517-22, 2016.
, “Assessment and Reporting of Driving Fitness in Patients with Dementia in Clinical Practice: Data from SveDem, the Swedish Dementia Registry.”, J Alzheimers Dis, vol. 53, no. 2, pp. 631-8, 2016.
,